RhePro
@rheproat.bsky.social
🤰🏻RHEumatic diseases and rePROduction
✨Science meets care
Founded by Dr. A. Mazzucato-Puchner (Rheumatologist) & Ass.Prof. Dr. K. Rosta (OB/GYN)
www.rhepro.at
✨Science meets care
Founded by Dr. A. Mazzucato-Puchner (Rheumatologist) & Ass.Prof. Dr. K. Rosta (OB/GYN)
www.rhepro.at
Prof. Rosta is reporting live from #ESHRE in Paris 🇫🇷 Sharing the latest insights in #RhePro – where #Rheumatology meets #Reproduction. Exciting updates from the frontline of Research!
July 1, 2025 at 8:10 PM
Prof. Rosta is reporting live from #ESHRE in Paris 🇫🇷 Sharing the latest insights in #RhePro – where #Rheumatology meets #Reproduction. Exciting updates from the frontline of Research!
🧬 New #publication alert!
Our study on maternal antibody transfer in women with autoimmune diseases during pregnancy is out now in Journal of Autoimmunity!
Read more: doi.org/10.1016/j.ja...
#Immunology #Pregnancy #Autoimmune
Our study on maternal antibody transfer in women with autoimmune diseases during pregnancy is out now in Journal of Autoimmunity!
Read more: doi.org/10.1016/j.ja...
#Immunology #Pregnancy #Autoimmune
June 4, 2025 at 5:07 AM
🧬 New #publication alert!
Our study on maternal antibody transfer in women with autoimmune diseases during pregnancy is out now in Journal of Autoimmunity!
Read more: doi.org/10.1016/j.ja...
#Immunology #Pregnancy #Autoimmune
Our study on maternal antibody transfer in women with autoimmune diseases during pregnancy is out now in Journal of Autoimmunity!
Read more: doi.org/10.1016/j.ja...
#Immunology #Pregnancy #Autoimmune
Save the date for RheumaPreg 2025 Highlights Webinar! ⏰
Thanks to the inspiring leadership of the EULAR ReHFaP Study Group for making this possible.✨
Thanks to the inspiring leadership of the EULAR ReHFaP Study Group for making this possible.✨
May 23, 2025 at 7:27 PM
Save the date for RheumaPreg 2025 Highlights Webinar! ⏰
Thanks to the inspiring leadership of the EULAR ReHFaP Study Group for making this possible.✨
Thanks to the inspiring leadership of the EULAR ReHFaP Study Group for making this possible.✨
RheumaPreg– It’s a wrap!
A big thank you to all speakers, chairs and participants!
We shared knowledge, sparked ideas, and built bridges between rheumatology and reproductive medicine.
A big thank you to all speakers, chairs and participants!
We shared knowledge, sparked ideas, and built bridges between rheumatology and reproductive medicine.
May 10, 2025 at 3:15 PM
RheumaPreg– It’s a wrap!
A big thank you to all speakers, chairs and participants!
We shared knowledge, sparked ideas, and built bridges between rheumatology and reproductive medicine.
A big thank you to all speakers, chairs and participants!
We shared knowledge, sparked ideas, and built bridges between rheumatology and reproductive medicine.
Good morning from wonderful Vienna and our third day of #RheumaPreg2025!
A day full of lively debates, patient perspectives, and important conversations around long-term challenges and gender inclusivity in reproductive rheumatology.
Let’s dive in! 🤩
A day full of lively debates, patient perspectives, and important conversations around long-term challenges and gender inclusivity in reproductive rheumatology.
Let’s dive in! 🤩
May 10, 2025 at 6:16 AM
Good morning from wonderful Vienna and our third day of #RheumaPreg2025!
A day full of lively debates, patient perspectives, and important conversations around long-term challenges and gender inclusivity in reproductive rheumatology.
Let’s dive in! 🤩
A day full of lively debates, patient perspectives, and important conversations around long-term challenges and gender inclusivity in reproductive rheumatology.
Let’s dive in! 🤩
Today at the RheumaPreg 2025 we presented four posters featuring current data from the RhePro outpatient clinic.
May 9, 2025 at 4:26 PM
Today at the RheumaPreg 2025 we presented four posters featuring current data from the RhePro outpatient clinic.
IMPACT Trial
Certolizumab in high-risk pregnancies (APS + LAC):
• Complications: ↓ from 80% to 20%
• Gestational age: ↑ from 24 to 36.5 weeks
• Live births: ↑ from 38% to 93%
Huge congratulations to Jane Salmon & team – truly transformative results!
Certolizumab in high-risk pregnancies (APS + LAC):
• Complications: ↓ from 80% to 20%
• Gestational age: ↑ from 24 to 36.5 weeks
• Live births: ↑ from 38% to 93%
Huge congratulations to Jane Salmon & team – truly transformative results!
May 9, 2025 at 1:30 PM
IMPACT Trial
Certolizumab in high-risk pregnancies (APS + LAC):
• Complications: ↓ from 80% to 20%
• Gestational age: ↑ from 24 to 36.5 weeks
• Live births: ↑ from 38% to 93%
Huge congratulations to Jane Salmon & team – truly transformative results!
Certolizumab in high-risk pregnancies (APS + LAC):
• Complications: ↓ from 80% to 20%
• Gestational age: ↑ from 24 to 36.5 weeks
• Live births: ↑ from 38% to 93%
Huge congratulations to Jane Salmon & team – truly transformative results!
Day 2 of RheumaPreg 2025 is underway!
Today’s sessions focus on clinical research in pregnancy, obstetric APS, neonatal lupus, immunosuppression during pregnancy, and hormonal influences in rheumatic diseases.
Stay tuned for more insights and discussion.
Today’s sessions focus on clinical research in pregnancy, obstetric APS, neonatal lupus, immunosuppression during pregnancy, and hormonal influences in rheumatic diseases.
Stay tuned for more insights and discussion.
May 9, 2025 at 6:41 AM
Day 2 of RheumaPreg 2025 is underway!
Today’s sessions focus on clinical research in pregnancy, obstetric APS, neonatal lupus, immunosuppression during pregnancy, and hormonal influences in rheumatic diseases.
Stay tuned for more insights and discussion.
Today’s sessions focus on clinical research in pregnancy, obstetric APS, neonatal lupus, immunosuppression during pregnancy, and hormonal influences in rheumatic diseases.
Stay tuned for more insights and discussion.
RheumaPreg 2025 kicked off powerfully!
We learned so much from experts in rheumatology and obstetrics – about fertility and the placenta.
These insights are key to understanding pregnancy risks and improving care for women with rheumatic diseases.
A strong beginning to an important conversation!
We learned so much from experts in rheumatology and obstetrics – about fertility and the placenta.
These insights are key to understanding pregnancy risks and improving care for women with rheumatic diseases.
A strong beginning to an important conversation!
May 8, 2025 at 3:31 PM
RheumaPreg 2025 kicked off powerfully!
We learned so much from experts in rheumatology and obstetrics – about fertility and the placenta.
These insights are key to understanding pregnancy risks and improving care for women with rheumatic diseases.
A strong beginning to an important conversation!
We learned so much from experts in rheumatology and obstetrics – about fertility and the placenta.
These insights are key to understanding pregnancy risks and improving care for women with rheumatic diseases.
A strong beginning to an important conversation!
RheumaPreg 2025 starts today in Vienna!
From May 8–10, experts in rheumatology, immunology, and obstetrics will discuss pregnancy in rheumatic diseases, fertility, placental pathology, immune mechanisms, and clinical innovations.
We look forward to an inspiring congress!
From May 8–10, experts in rheumatology, immunology, and obstetrics will discuss pregnancy in rheumatic diseases, fertility, placental pathology, immune mechanisms, and clinical innovations.
We look forward to an inspiring congress!
May 8, 2025 at 8:49 AM
RheumaPreg 2025 starts today in Vienna!
From May 8–10, experts in rheumatology, immunology, and obstetrics will discuss pregnancy in rheumatic diseases, fertility, placental pathology, immune mechanisms, and clinical innovations.
We look forward to an inspiring congress!
From May 8–10, experts in rheumatology, immunology, and obstetrics will discuss pregnancy in rheumatic diseases, fertility, placental pathology, immune mechanisms, and clinical innovations.
We look forward to an inspiring congress!
RhePro – Where Science meets Hope
We are a #gynecologist & a #rheumatologist united by a shared passion.✨
That’s why we founded a specialized outpatient clinic and launched research projects.🤰🏻
Let’s build awareness and support — together.
#Expertise #Research #Empowerment
A. Mazzucato & K. Rosta
We are a #gynecologist & a #rheumatologist united by a shared passion.✨
That’s why we founded a specialized outpatient clinic and launched research projects.🤰🏻
Let’s build awareness and support — together.
#Expertise #Research #Empowerment
A. Mazzucato & K. Rosta
May 6, 2025 at 9:31 PM
RhePro – Where Science meets Hope
We are a #gynecologist & a #rheumatologist united by a shared passion.✨
That’s why we founded a specialized outpatient clinic and launched research projects.🤰🏻
Let’s build awareness and support — together.
#Expertise #Research #Empowerment
A. Mazzucato & K. Rosta
We are a #gynecologist & a #rheumatologist united by a shared passion.✨
That’s why we founded a specialized outpatient clinic and launched research projects.🤰🏻
Let’s build awareness and support — together.
#Expertise #Research #Empowerment
A. Mazzucato & K. Rosta